Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Caracsol** is a fixed-dose ophthalmic solution marketed by Dey's Medical Stores for ophthalmic use. Its labeled active ingredients are calcium chloride, potassium iodide, and sodium chloride. It is used in India as an ophthalmologist-directed supportive treatment for cataract-associated lens opacity and related visual disturbance. The formulation is intended to support ocular electrolyte and osmotic balance; it does not have a defined selective molecular target or a validated targeted pharmacologic mechanism for reversing cataract. Public product listings identify potassium iodide, rather than potassium chloride, as the potassium-containing active ingredient. ([1mg.com](https://www.1mg.com/drugs/caracsol-eye-drop-185131))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Caracsol.